与艾滋病毒感染者感染COVID-19相关的因素。在哥伦比亚队列中嵌套的病例对照研究

Q3 Medicine
Infectio Pub Date : 2023-09-06 DOI:10.22354/24223794.1139
Juan Carlos Alzate-Angel, Melissa Gutierrez-Gomez, Hector Mueses-Marin, Sandra Valderrama-Beltran, Beatriz Hernandez, Otto Sussmann-Peña, Ernesto Martinez-Buitrago
{"title":"与艾滋病毒感染者感染COVID-19相关的因素。在哥伦比亚队列中嵌套的病例对照研究","authors":"Juan Carlos Alzate-Angel, Melissa Gutierrez-Gomez, Hector Mueses-Marin, Sandra Valderrama-Beltran, Beatriz Hernandez, Otto Sussmann-Peña, Ernesto Martinez-Buitrago","doi":"10.22354/24223794.1139","DOIUrl":null,"url":null,"abstract":"Objective: People living with HIV (PLWH); can be especially vulnerable to the effects of SARS Co V 2 and COVID 19. In this study, we evaluate the factors associated with acquiring COVID 19 and the severity of the infection among PLWH.&#x0D; Materials and methods: Through a case-control study nested in a cohort, where cases were PLWH diagnosed with COVID 19; and controls were PLWH without the infection, 476 people were evaluated between May 1, 2020, and February 28, 2021. A univariate analysis was performed with the variables considered candidates. Binary logistic regression models were conducted for the COVID 19 outcome, and among those diagnosed with the infection, regression models for the outcome of hospitalization vs. outpatient treatment.&#x0D; Results: Among 238 PLWH diagnosed with COVID 19, receiving integrase inhibitors p < 0.001 (CI 95% 0.27,0.72) or protease inhibitors p 0.034 (CI 95%0.42,0.97) within their antiretroviral regime, was associated with a lower probability of developing COVID 19. 196 (82,35%) of the 238 cases received outpatient treatment, and 42 (17,64%) required hospitalization. In this case, being older than 50 years p < 0.001 (CI 95% 1.8,9.64) and having obesity as a comorbidity p 0.017 (CI 95% 1.34,17.93) increased the possibility of requiring hospitalization, while receiving antiretroviral treatment or having received vaccination against influenza, decreased the likelihood of this outcome.&#x0D; Conclusions: There are still many questions regarding whether there is a differential risk of acquiring COVID 19 among PLWH. Antiretroviral treatment with inte­grase or protease inhibitors; was associated with a lower probability of developing the co-infection. Some factors related to comorbidities, such as older age and obesity, draw attention to possible risk factors for hospitalization in this population. Discussing the feasibility of new studies with proposed causal hypotheses that allow directing the research designs toward a more precise answer to these questions is essential","PeriodicalId":38132,"journal":{"name":"Infectio","volume":"27 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors associated with COVID-19 infection in People Living with HIV. A case-control study nested in a Colombian cohort\",\"authors\":\"Juan Carlos Alzate-Angel, Melissa Gutierrez-Gomez, Hector Mueses-Marin, Sandra Valderrama-Beltran, Beatriz Hernandez, Otto Sussmann-Peña, Ernesto Martinez-Buitrago\",\"doi\":\"10.22354/24223794.1139\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: People living with HIV (PLWH); can be especially vulnerable to the effects of SARS Co V 2 and COVID 19. In this study, we evaluate the factors associated with acquiring COVID 19 and the severity of the infection among PLWH.&#x0D; Materials and methods: Through a case-control study nested in a cohort, where cases were PLWH diagnosed with COVID 19; and controls were PLWH without the infection, 476 people were evaluated between May 1, 2020, and February 28, 2021. A univariate analysis was performed with the variables considered candidates. Binary logistic regression models were conducted for the COVID 19 outcome, and among those diagnosed with the infection, regression models for the outcome of hospitalization vs. outpatient treatment.&#x0D; Results: Among 238 PLWH diagnosed with COVID 19, receiving integrase inhibitors p < 0.001 (CI 95% 0.27,0.72) or protease inhibitors p 0.034 (CI 95%0.42,0.97) within their antiretroviral regime, was associated with a lower probability of developing COVID 19. 196 (82,35%) of the 238 cases received outpatient treatment, and 42 (17,64%) required hospitalization. In this case, being older than 50 years p < 0.001 (CI 95% 1.8,9.64) and having obesity as a comorbidity p 0.017 (CI 95% 1.34,17.93) increased the possibility of requiring hospitalization, while receiving antiretroviral treatment or having received vaccination against influenza, decreased the likelihood of this outcome.&#x0D; Conclusions: There are still many questions regarding whether there is a differential risk of acquiring COVID 19 among PLWH. Antiretroviral treatment with inte­grase or protease inhibitors; was associated with a lower probability of developing the co-infection. Some factors related to comorbidities, such as older age and obesity, draw attention to possible risk factors for hospitalization in this population. Discussing the feasibility of new studies with proposed causal hypotheses that allow directing the research designs toward a more precise answer to these questions is essential\",\"PeriodicalId\":38132,\"journal\":{\"name\":\"Infectio\",\"volume\":\"27 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectio\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22354/24223794.1139\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectio","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22354/24223794.1139","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:HIV感染者(PLWH);尤其容易受到SARS病毒和COVID - 19的影响。在本研究中,我们评估了与感染COVID - 19相关的因素以及PLWH感染的严重程度。材料和方法:通过在队列中嵌套的病例对照研究,病例为诊断为COVID - 19的PLWH;在2020年5月1日至2021年2月28日期间,对476人进行了评估。对考虑的候选变量进行单因素分析。对新冠肺炎转归建立二元logistic回归模型,在确诊感染人群中建立住院转归与门诊转归的回归模型。 结果:在238例确诊为COVID - 19的PLWH中,接受整合酶抑制剂p <0.001 (CI 95% 0.27,0.72)或蛋白酶抑制剂p 0.034 (CI 95%0.42,0.97)在抗逆转录病毒治疗方案中与较低的发生COVID - 19的可能性相关。238例患者中门诊196例(82.35%),住院42例(17.64%)。在这种情况下,年龄超过50岁p <p 0.017 (CI 95% 1.34,17.93)增加了需要住院治疗的可能性,而接受抗逆转录病毒治疗或接种流感疫苗降低了这一结果的可能性。 结论:hiv感染者感染风险是否存在差异仍存在诸多问题。整合酶或蛋白酶抑制剂抗逆转录病毒治疗;与发生合并感染的可能性较低有关。与合并症相关的一些因素,如年龄较大和肥胖,引起人们对这一人群住院治疗的可能危险因素的关注。讨论新研究的可行性与提出的因果假设,允许指导研究设计更精确地回答这些问题是必不可少的
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Factors associated with COVID-19 infection in People Living with HIV. A case-control study nested in a Colombian cohort
Objective: People living with HIV (PLWH); can be especially vulnerable to the effects of SARS Co V 2 and COVID 19. In this study, we evaluate the factors associated with acquiring COVID 19 and the severity of the infection among PLWH. Materials and methods: Through a case-control study nested in a cohort, where cases were PLWH diagnosed with COVID 19; and controls were PLWH without the infection, 476 people were evaluated between May 1, 2020, and February 28, 2021. A univariate analysis was performed with the variables considered candidates. Binary logistic regression models were conducted for the COVID 19 outcome, and among those diagnosed with the infection, regression models for the outcome of hospitalization vs. outpatient treatment. Results: Among 238 PLWH diagnosed with COVID 19, receiving integrase inhibitors p < 0.001 (CI 95% 0.27,0.72) or protease inhibitors p 0.034 (CI 95%0.42,0.97) within their antiretroviral regime, was associated with a lower probability of developing COVID 19. 196 (82,35%) of the 238 cases received outpatient treatment, and 42 (17,64%) required hospitalization. In this case, being older than 50 years p < 0.001 (CI 95% 1.8,9.64) and having obesity as a comorbidity p 0.017 (CI 95% 1.34,17.93) increased the possibility of requiring hospitalization, while receiving antiretroviral treatment or having received vaccination against influenza, decreased the likelihood of this outcome. Conclusions: There are still many questions regarding whether there is a differential risk of acquiring COVID 19 among PLWH. Antiretroviral treatment with inte­grase or protease inhibitors; was associated with a lower probability of developing the co-infection. Some factors related to comorbidities, such as older age and obesity, draw attention to possible risk factors for hospitalization in this population. Discussing the feasibility of new studies with proposed causal hypotheses that allow directing the research designs toward a more precise answer to these questions is essential
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Infectio
Infectio Medicine-Pharmacology (medical)
CiteScore
1.50
自引率
0.00%
发文量
18
审稿时长
39 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信